StonvexLoading…
StonvexStonvexStonvexCore line items from STEP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $1.17B | $711.63M | $-67.57M | $1.37B |
Operating Income | $-222.03M | $195.40M | $-41.45M | $512.58M |
Net Income | $-179.56M | $58.09M | $-18.40M | $193.88M |
EPS (Diluted) | $-2.52 | $0.91 | $-0.30 | $3.84 |
Total Assets | $4.59B | $3.79B | $3.50B | $4.19B |
Total Liabilities | $2.81B | $1.92B | $1.84B | $2.36B |
Cash & Equivalents | $289.80M | $182.31M | $129.52M | $116.39M |
Free Cash Flow OCF − CapEx | $59.83M | $141.91M | $145.56M | $212.18M |
Shares Outstanding | 71.14M | 66.54M | 61.88M | 53.60M |